The independent source for health policy research, polling, and news.
401 - 420 of 686 Results
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN’s Julie Rovner to discuss these issues and take questions from a live studio audience.
Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.
The governor of California has proposed some big ideas. Who knows whether he can pull them off, but there’s reason for hope.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son — and others who order medicine by mail — could depend on it, she says.
Just hours into his tenure as California’s new governor, Democrat Gavin Newsom proposed major plans to insure more Californians, including state-funded financial aid for health insurance and a requirement for Californians to have coverage.
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
The program that provides health care for about half of the U.S. territory’s population cannot afford to cover the drugs.
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners’ questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner.
Utah's Orrin Hatch is leaving the Senate, after 42 years. The Republican led bipartisan efforts to provide health care to more kids and AIDS patients. He also thrived on donations from the drug industry.
© 2026 KFF